131 related articles for article (PubMed ID: 33231795)
1. Assessment of the Chemosensitivity of Uveal Melanoma Cells Ex Vivo.
Saakyan SV; Tsygankov АY; Moiseeva NI; Karamysheva АF; Garri DD
Bull Exp Biol Med; 2020 Nov; 170(1):142-147. PubMed ID: 33231795
[TBL] [Abstract][Full Text] [Related]
2. Clinical evaluation of in vitro chemosensitivity testing: the example of uveal melanoma.
Terheyden P; Bröcker EB; Becker JC
J Cancer Res Clin Oncol; 2004 Jul; 130(7):395-9. PubMed ID: 15160290
[TBL] [Abstract][Full Text] [Related]
3. Treosulfan and gemcitabine in metastatic uveal melanoma patients: results of a multicenter feasibility study.
Pföhler C; Cree IA; Ugurel S; Kuwert C; Haass N; Neuber K; Hengge U; Corrie PG; Zutt M; Tilgen W; Reinhold U
Anticancer Drugs; 2003 Jun; 14(5):337-40. PubMed ID: 12782938
[TBL] [Abstract][Full Text] [Related]
4. Phase I trial combining gemcitabine and treosulfan in advanced cutaneous and uveal melanoma patients.
Corrie PG; Shaw J; Spanswick VJ; Sehmbi R; Jonson A; Mayer A; Bulusu R; Hartley JA; Cree IA
Br J Cancer; 2005 Jun; 92(11):1997-2003. PubMed ID: 15886706
[TBL] [Abstract][Full Text] [Related]
5. A clinical phase I trial of gemcitabine and treosulfan in uveal melanoma and other solid tumours.
Keilholz U; Schuster R; Schmittel A; Bechrakis N; Siehl J; Foerster MH; Thiel E
Eur J Cancer; 2004 Sep; 40(14):2047-52. PubMed ID: 15341977
[TBL] [Abstract][Full Text] [Related]
6. The in vitro effect of gefitinib ('Iressa') alone and in combination with cytotoxic chemotherapy on human solid tumours.
Knight LA; Di Nicolantonio F; Whitehouse P; Mercer S; Sharma S; Glaysher S; Johnson P; Cree IA
BMC Cancer; 2004 Nov; 4():83. PubMed ID: 15560844
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the ex vivo chemosensitivity of uveal and cutaneous melanoma.
Neale MH; Myatt NE; Khoury GG; Weaver P; Lamont A; Hungerford JL; Kurbacher CM; Hall P; Corrie PG; Cree IA
Melanoma Res; 2001 Dec; 11(6):601-9. PubMed ID: 11725206
[TBL] [Abstract][Full Text] [Related]
8. A two-cohort phase II clinical trial of gemcitabine plus treosulfan in patients with metastatic uveal melanoma.
Schmittel A; Schuster R; Bechrakis NE; Siehl JM; Foerster MH; Thiel E; Keilholz U
Melanoma Res; 2005 Oct; 15(5):447-51. PubMed ID: 16179873
[TBL] [Abstract][Full Text] [Related]
9. A randomized phase II trial of gemcitabine plus treosulfan versus treosulfan alone in patients with metastatic uveal melanoma.
Schmittel A; Schmidt-Hieber M; Martus P; Bechrakis NE; Schuster R; Siehl JM; Foerster MH; Thiel E; Keilholz U
Ann Oncol; 2006 Dec; 17(12):1826-9. PubMed ID: 16971664
[TBL] [Abstract][Full Text] [Related]
10. The ex vivo chemosensitivity profile of choroidal melanoma.
Myatt N; Cree IA; Kurbacher CM; Foss AJ; Hungerford JL; Plowman PN
Anticancer Drugs; 1997 Sep; 8(8):756-62. PubMed ID: 9396619
[TBL] [Abstract][Full Text] [Related]
11. Treosulfan and gemcitabine.
Cree IA; Neale MH; Reinhold U; Kurbacher CM
J Cancer Res Clin Oncol; 2005 May; 131(5):329-30; author reply 331. PubMed ID: 15700153
[No Abstract] [Full Text] [Related]
12. Combination chemotherapy for choroidal melanoma: ex vivo sensitivity to treosulfan with gemcitabine or cytosine arabinoside.
Neale MH; Myatt N; Cree IA; Kurbacher CM; Foss AJ; Hungerford JL; Plowman PN
Br J Cancer; 1999 Mar; 79(9-10):1487-93. PubMed ID: 10188895
[TBL] [Abstract][Full Text] [Related]
13. Cisplatin, gemcitabine and treosulfan is effective in chemotherapy-pretreated relapsed stage IV uveal melanoma patients.
Atzpodien J; Terfloth K; Fluck M; Reitz M
Cancer Chemother Pharmacol; 2008 Sep; 62(4):685-8. PubMed ID: 18084763
[TBL] [Abstract][Full Text] [Related]
14. Phase II trial of cisplatin, gemcitabine and treosulfan in patients with metastatic uveal melanoma.
Schmittel A; Scheulen ME; Bechrakis NE; Strumberg D; Baumgart J; Bornfeld N; Foerster MH; Thiel E; Keilholz U
Melanoma Res; 2005 Jun; 15(3):205-7. PubMed ID: 15917703
[TBL] [Abstract][Full Text] [Related]
15. Fucoidan Does Not Exert Anti-Tumorigenic Effects on Uveal Melanoma Cell Lines.
Dithmer M; Kirsch AM; Richert E; Fuchs S; Wang F; Schmidt H; Coupland SE; Roider J; Klettner A
Mar Drugs; 2017 Jun; 15(7):. PubMed ID: 28640204
[TBL] [Abstract][Full Text] [Related]
16. A prospective single arm phase II study of dacarbazine and treosulfan as first-line therapy in metastatic uveal melanoma.
O'Neill PA; Butt M; Eswar CV; Gillis P; Marshall E
Melanoma Res; 2006 Jun; 16(3):245-8. PubMed ID: 16718271
[TBL] [Abstract][Full Text] [Related]
17. The Anti-malarial Drug Artesunate Blocks Wnt/β-catenin Pathway and Inhibits Growth, Migration and Invasion of Uveal Melanoma Cells.
Zheng L; Pan J
Curr Cancer Drug Targets; 2018; 18(10):988-998. PubMed ID: 29692251
[TBL] [Abstract][Full Text] [Related]
18. The role of Bax and Bcl-2 in gemcitabine-mediated cytotoxicity in uveal melanoma cells.
Wang J; Jia R; Zhang Y; Xu X; Song X; Zhou Y; Zhang H; Ge S; Fan X
Tumour Biol; 2014 Feb; 35(2):1169-75. PubMed ID: 24014050
[TBL] [Abstract][Full Text] [Related]
19. Effects of ranibizumab and amfenac on the functional abilities and radiosensitivity of uveal melanoma cells.
Bravo-Filho V; Logan P; Zoroquiain P; Aldrees S; Vilà N; Oweida A; Belfort Neto R; Burnier MN
Arq Bras Oftalmol; 2019; 82(1):38-44. PubMed ID: 30403264
[TBL] [Abstract][Full Text] [Related]
20. Curcumin induces cell death in human uveal melanoma cells through mitochondrial pathway.
Lu C; Song E; Hu DN; Chen M; Xue C; Rosen R; McCormick SA
Curr Eye Res; 2010 Apr; 35(4):352-60. PubMed ID: 20373902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
